Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

to connected objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Journal of Experimental & Clinical Cancer Research 40 (2021): 248.

Event: Veröffentlichung

(where): Erlangen

(who): Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

(when): 2021

Creator: Parma, Beatrice
Ramesh, Vignesh
Gollavilli, Paradesi Naidu
Siddiqui, Aarif
Pinna, Luisa
Schwab, Annemarie
Marschall, Sabine
Zhang, Shuman
Pilarsky, Christian
Napoli, Francesca
Volante, Marco
Urbanczyk, Sophia
Mielenz, Dirk
Schrøder, Henrik Daa
Stemmler, Marc
Wurdak, Heiko
Ceppi, Paolo

DOI: 10.1186/s13046-021-02049-8

URN: urn:nbn:de:bvb:29-opus4-177032

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Parma, Beatrice
Ramesh, Vignesh
Gollavilli, Paradesi Naidu
Siddiqui, Aarif
Pinna, Luisa
Schwab, Annemarie
Marschall, Sabine
Zhang, Shuman
Pilarsky, Christian
Napoli, Francesca
Volante, Marco
Urbanczyk, Sophia
Mielenz, Dirk
Schrøder, Henrik Daa
Stemmler, Marc
Wurdak, Heiko
Ceppi, Paolo
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

2021

Other Objects (12)

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Hochschulschrift

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Hochschulschrift

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Hochschulschrift

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial impairment in HIV-infected children

Integrated molecular portrait of non-small cell lung cancers

Targeting cancers through TCR-peptide/MHC interactions

Targeting the immune milieu in gastrointestinal cancers

Drug-induced mitochondrial impairment in liver cells

Molecular targeting of metastatic and multidrug resistant cancers

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Related objects

Reset password